Envista Holdings Corp

Envista Holdings Corp(NVST)の株式分析

$27.130

-0.307 (-1.13%)終値時点

Loading chart…
High
27.560
Open
27.410
VWAP
27.26
Vol
1.21M
Mkt Cap
2.83B
Low
27.080
Amount
32.98M
EV/EBITDA, TTM
8.79

Envista Holdings Corporation provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, as well as to improve the aesthetics of the human smile. The Company is a provider of a range of solutions to support dental implants, orthodontic treatments, dental diagnostics, general dental consumable products, equipment and services. Its segments include Specialty Products & Technologies and Equipment & Consumables. The Specialty Products & Technologies segment primarily develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, lab products, and loupes. The Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems.

AI analysis of Envista Holdings Corp (NVST)

buy

Envista Holdings Corp is a good buy right now due to its strong growth potential, evidenced by a 5% core growth in Q2 2026 and a projected adjusted EPS growth of 58%. The current price is $27.13, which is below the average analyst price target of $29, indicating potential upside. Additionally, the company has raised its 2026 core growth expectations to 3.5% to 4.5%, which supports a bullish outlook. However, the RSI is currently at 38.305, indicating that the stock may be oversold, presenting a buying opportunity.

バリュエーション指標

The current forward P/E ratio for Envista Holdings Corp (NVST) is 20.33, compared to its 5-year average forward P/E of 19.91.

Forward P/E

Fair
5Y Average P/E
19.91
Current P/E
20.33
割高
23.80
割安
16.02

Forward EV/EBITDA

Undervalued
5Y Average EV/EBITDA
12.38
Current EV/EBITDA
8.79
割高
14.44
割安
10.32

Forward P/S

Fair
5Y Average P/S
1.78
Current P/S
1.48
割高
2.34
割安
1.22

Alphio AI Price Scenarios for NVST

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%NVST

$18.76

シナリオ価格

B

Base

Base · 50%NVST

$17.69

シナリオ価格

B

Bear

Bear · 25%NVST

$15.35

シナリオ価格

Whales holding NVST

I

Integral Health Asset Management, LLC

+ HoldingNVST

+15.08%

3M Return

A

Ariel Investments, LLC

+ HoldingNVST

+3.35%

3M Return

P

Palisade Capital Management, LP

+ HoldingNVST

+2.87%

3M Return

P

Paradice Investment Management Pty Ltd.

+ HoldingNVST

+2.38%

3M Return

A

Asahi Life Asset Management Co.,Ltd.

+ HoldingNVST

+1.95%

3M Return

G

Gates Capital Management, Inc.

+ HoldingNVST

-1.91%

3M Return

イベントタイムライン

2026-08-05 (ET)

16:30:00

Company Reports Q2 Revenue of $731M, Exceeds Expectations

16:30:00

Raises 2026 Revenue Growth Outlook to 3.5%-4.5%

2026-05-06 (ET)

20:00:00

Strong Earnings in Tech Push S&P 500 to Record Highs

17:00:00

Company Confirms FY26 Core Sales Growth 2%-4%

17:00:00

Company Reports Q1 Revenue of $706M, Exceeds Expectations

ニュース

NVST FAQ — answered by Alphio AI

Envista Holdings Corporation provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, as well as to improve the aesthetics of the human smile. The Company is a provider of a range of solutions to support dental implants, orthodontic treatments, dental diagnostics, general dental consumable products, equipment and services. Its segments include Specialty Products & Technologies and Equipment & Consumables. The Specialty Products & Technologies segment primarily develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, lab products, and loupes. The Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems. It operates in the Healthcare sector (DENTAL EQUIPMENT & SUPPLIES industry).

Envista Holdings Corp is a good buy right now due to its strong growth potential, evidenced by a 5% core growth in Q2 2026 and a projected adjusted EPS growth of 58%. The current price is $27.13, which is below the average analyst price target of $29, indicating potential upside. Additionally, the company has raised its 2026 core growth expectations to 3.5% to 4.5%, which supports a bullish outlook. However, the RSI is currently at 38.305, indicating that the stock may be oversold, presenting a buying opportunity.

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

無料で始める